A novel lethal recognizable polymicrogyric syndrome caused by ATP1A2 homozygous truncating variants.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 22 11 2018
revised: 20 06 2019
accepted: 11 07 2019
pubmed: 15 10 2019
medline: 27 5 2020
entrez: 15 10 2019
Statut: ppublish

Résumé

Polymicrogyria is a heterogeneous malformation of cortical development microscopically defined by an excessive folding of the cortical mantle resulting in small gyri with a fused surface. Polymicrogyria is responsible for a wide range of neurological symptoms (e.g. epilepsy, intellectual disability, motor dysfunction). Most cases have a supposed environmental clastic vascular or infectious origin but progress in genomics has revealed new monogenic entities. We report four cases from two independent families sharing a common recognizable lethal syndromic polymicrogyria of autosomal recessive inheritance. Beyond diffuse polymicrogyria detected prenatally, pathological examination revealed a common pattern associating meningeal arterial calcifications, necrotic and calcified areas in basal ganglia, dentato-olivary dysplasia and severe hypoplasia/agenesis of the pyramidal tracts. In all affected cases, exome sequencing showed a pathogenic homozygous nonsense ATP1A2 variant. This resulted in absence of immunodetectable ATP1A2 protein in two brains analysed. ATP1A2 encodes the alpha-2 isoform of the Na+/K+-ATPase, which is highly expressed in brain tissues and has previously been related to familial hemiplegic migraine (MIM#602481) and alternating hemiplegia of childhood (MIM#104290). Through the description of this genetic entity, we emphasize the possibility of dual mode of transmission for disease-causing genes and provide the key neuropathological features that should prompt geneticists to test for mutations in the ATP1A2 gene.

Identifiants

pubmed: 31608932
pii: 5570864
doi: 10.1093/brain/awz272
doi:

Substances chimiques

ATP1A2 protein, human EC 3.6.1.-
Sodium-Potassium-Exchanging ATPase EC 7.2.2.13

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3367-3374

Informations de copyright

© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Nicolas Chatron (N)

Genetics Department, Hospices Civils de Lyon, Lyon, France.
GENDEV Team, CRNL, INSERM U1028, CNRS UMR 5292, UCBL1, Lyon, France.

Sara Cabet (S)

Imagerie pédiatrique et fœtale, UCBL Lyon I, Hôpital Femme Mère Enfant, Lyon-Bron, France.

Eudeline Alix (E)

Genetics Department, Hospices Civils de Lyon, Lyon, France.

Annie Buenerd (A)

Institut de Pathologie Multi-sites des HCL/Centre de Pathologie et Fœtopathologie Est, Lyon, France.

Phillip Cox (P)

Department of Histopathology, Birmingham Women's and Children's Hospital NHSFT, Birmingham, UK.

Laurent Guibaud (L)

Imagerie pédiatrique et fœtale, UCBL Lyon I, Hôpital Femme Mère Enfant, Lyon-Bron, France.

Audrey Labalme (A)

Genetics Department, Hospices Civils de Lyon, Lyon, France.

Peter Marks (P)

West Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital NHSFT, Birmingham, UK.

Deborah Osio (D)

West Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital NHSFT, Birmingham, UK.

Audrey Putoux (A)

Genetics Department, Hospices Civils de Lyon, Lyon, France.
GENDEV Team, CRNL, INSERM U1028, CNRS UMR 5292, UCBL1, Lyon, France.

Damien Sanlaville (D)

Genetics Department, Hospices Civils de Lyon, Lyon, France.
GENDEV Team, CRNL, INSERM U1028, CNRS UMR 5292, UCBL1, Lyon, France.

Gaetan Lesca (G)

Genetics Department, Hospices Civils de Lyon, Lyon, France.
GENDEV Team, CRNL, INSERM U1028, CNRS UMR 5292, UCBL1, Lyon, France.

Alexandre Vasiljevic (A)

Institut de Pathologie Multi-sites des HCL/Centre de Pathologie et Fœtopathologie Est, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH